Mirati Therapeutics, Inc.

ORBIMED ADVISORS LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

1,959,050

Value ($000)

85,336

Weight

1.8%

2013 Q4 - 2023 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	85,336	1.8%	1,959,050	9/30/2023
2023 Q2	8/14/2023	33,010	0.6%	913,650	6/30/2023
2023 Q1	5/15/2023	33,970	0.7%	913,650	3/31/2023
2022 Q4	2/14/2023	58,164	1.1%	1,283,692	12/31/2022
2022 Q3	11/14/2022	99,095	1.9%	1,418,892	9/30/2022
2022 Q2	8/15/2022	73,199	1.3%	1,090,400	6/30/2022
2022 Q1	5/16/2022	134,060	2.2%	1,630,500	3/31/2022
2021 Q4	2/14/2022	209,239	2.7%	1,426,400	12/31/2021
2021 Q3	11/15/2021	242,933	2.8%	1,373,200	9/30/2021
2021 Q2	8/16/2021	204,206	2.1%	1,264,200	6/30/2021
2021 Q1	5/17/2021	209,192	2.0%	1,221,200	3/31/2021
2020 Q4	2/16/2021	251,554	2.2%	1,145,300	12/31/2020
2020 Q3	11/16/2020	218,688	2.8%	1,317,000	9/30/2020
2020 Q2	8/14/2020	151,172	2.1%	1,324,100	6/30/2020
2020 Q1	5/15/2020	109,409	1.9%	1,423,300	3/31/2020
2019 Q4	2/14/2020	172,750	2.5%	1,340,600	12/31/2019
2014 Q1	5/15/2014	24,302	0.3%	1,274,332	3/31/2014
2013 Q4	2/14/2014	21,192	0.3%	1,274,332	12/31/2013